|
1
|
But DY, Lai CL and Yuen MF: Natural
history of hepatitis-related hepatocellular carcinoma. World J
Gastroenterol. 14:1652–1656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hao K, Luk JM, Lee NP, Mao M, Zhang C,
Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC and Poon RT: Predicting
prognosis in hepatocellular carcinoma after curative surgery with
common clinicopathologic parameters. BMC Cancer. 9:3892009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sangiovanni A and Colombo M: Treatment of
hepatocellular carcinoma: Beyond international guidelines. Liver
Int. 36(Suppl 1): 124–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Invernizzi F, Viganò M, Grossi G and
Lampertico P: The prognosis and management of inactive HBV
carriers. Liver Int. 36(Suppl 1): 100–104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seki S, Nakashima H, Nakashima M and
Kinoshita M: Antitumor immunity produced by the liver Kupffer
cells, NK cells, NKT cells, and CD8 CD122 T cells. Clin Dev
Immunol. 2011:8683452011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geissler M, Mohr L and Blum HE:
Immunotherapy of hepatocellular carcinoma. Dtsch Med Wochenschr.
126:1464–1466. 2001.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gersuk GM, Westermark B, Mohabeer AJ,
Challita PM, Pattamakom S and Pattengale PK: Inhibition of human
natural killer cell activity by platelet-derived growth factor
(PDGF). III. Membrane binding studies and differential biological
effect of recombinant PDGF isoforms. Scand J Immunol. 33:521–532.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barkholt L, Alici E, Conrad R, Sutlu T,
Gilljam M, Stellan B, Christensson B, Guven H, Björkström NK,
Söderdahl G, et al: Safety analysis of ex vivo-expanded NK and
NK-like T cells administered to cancer patients: A phase I clinical
study. Immunotherapy. 1:753–764. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doskali M, Tanaka Y, Ohira M, Ishiyama K,
Tashiro H, Chayama K and Ohdan H: Possibility of adoptive
immunotherapy with peripheral blood-derived
CD3−CD56+ and CD3+CD56+
cells for inducing antihepatocellular carcinoma and antihepatitis C
virus activity. J Immunother. 34:129–138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang X, Liang L, Zhang XF, Jia HL, Qin Y,
Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, et al: MicroRNA-26a
suppresses tumor growth and metastasis of human hepatocellular
carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology.
58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ciaglia E, Pisanti S, Picardi P, Laezza C,
Sosa S, Tubaro A, Vitale M, Gazzerro P, Malfitano AM and Bifulco M:
N6-isopentenyladenosine affects cytotoxic activity and cytokines
production by IL-2 activated NK cells and exerts topical
anti-inflammatory activity in mice. Pharmacol Res. 89:1–10. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu LY, Zhou J, Liu YZ and Pan WD:
Prognostic significance of natural killer cell infiltration in
hepatocellular carcinoma. Ai Zheng. 28:1198–1202. 2009.(In
Chinese). PubMed/NCBI
|
|
13
|
Matsuoka S, Maeda N, Izumiya C, Yamashita
C, Nishimori Y and Fukaya T: Expression of inhibitory-motif killer
immunoglobulin-like receptor, KIR2DL1, is increased in natural
killer cells from women with pelvic endometriosis. Am J Reprod
Immunol. 53:249–254. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li T, Yang Y, Hua X, Wang G, Liu W, Jia C,
Tai Y, Zhang Q and Chen G: Hepatocellular carcinoma-associated
fibroblasts trigger NK cell dysfunction via PGE2 and IDO. Cancer
Lett. 318:154–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao
D, Liu Y, Zhu F, Zhang L, Sun W, et al: T cell immunoglobulin- and
mucin-domain-containing molecule-3 (Tim-3) mediates natural killer
cell suppression in chronic hepatitis B. J Hepatol. 52:322–329.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ohira M, Nishida S, Tryphonopoulos P,
Tekin A, Selvaggi G, Moon J, Levi D, Ricordi C, Ishiyama K, Tanaka
Y, et al: Clinical-scale isolation of interleukin-2-stimulated
liver natural killer cells for treatment of liver transplantation
with hepatocellular carcinoma. Cell Transplant. 21:1397–1406. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsunematsu H, Tatsumi T, Kohga K, Yamamoto
M, Aketa H, Miyagi T, Hosui A, Hiramatsu N, Kanto T, Hayashi N and
Takehara T: Fibroblast growth factor-2 enhances NK sensitivity of
hepatocellular carcinoma cells. Int J Cancer. 130:356–364. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mikuriya Y, Tashiro H, Kuroda S, Nambu J,
Kobayashi T, Amano H, Tanaka Y and Ohdan H: Fatty liver creates a
pro-metastatic microenvironment for hepatocellular carcinoma
through activation of hepatic stellate cells. Int J Cancer.
136:E3–E13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Faridi RM, Das V, Tripthi G, Talwar S,
Parveen F and Agrawal S: Influence of activating and inhibitory
killer immunoglobulin-like receptors on predisposition to recurrent
miscarriages. Hum Reprod. 24:1758–1764. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maat W, van der Slik AR, Verhoeven DH,
Alizadeh BZ, Ly LV, Verduijn W, Luyten GP, Mulder A, van Hall T,
Koning F, et al: Evidence for natural killer cell-mediated
protection from metastasis formation in uveal melanoma patients.
Invest Ophthalmol Vis Sci. 50:2888–2895. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Uemura A, Takehara T, Miyagi T, Suzuki T,
Tatsumi T, Ohkawa K, Kanto T, Hiramatsu N and Hayashi N: Natural
killer cell is a major producer of interferon gamma that is
critical for the IL-12-induced anti-tumor effect in mice. Cancer
Immunol Immunother. 59:453–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y, Kuang DM, Pan WD, Wan YL, Lao XM,
Wang D, Li XF and Zheng L: Monocyte/macrophage-elicited natural
killer cell dysfunction in hepatocellular carcinoma is mediated by
CD48/2B4 interactions. Hepatology. 57:1107–1116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoon JC, Lim JB, Park JH and Lee JM:
Cell-to-cell contact with hepatitis C virus-infected cells reduces
functional capacity of natural killer cells. J Virol.
85:12557–12569. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamagiwa S, Kamimura H and Ichida T:
Natural killer cell receptors and their ligands in liver diseases.
Med Mol Morphol. 42:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hoechst B, Voigtlaender T, Ormandy L,
Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten
TF and Korangy F: Myeloid derived suppressor cells inhibit natural
killer cells in patients with hepatocellular carcinoma via the
NKp30 receptor. Hepatology. 50:799–807. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Konjević G, Mirjacić Martinović K, Vuletić
A, Jović V, Jurisić V, Babović N and Spuzić I: Low expression of
CD161 and NKG2D activating NK receptor is associated with impaired
NK cell cytotoxicity in metastatic melanoma patients. Clin Exp
Metastasis. 24:1–11. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kamimura H, Yamagiwa S, Tsuchiya A,
Takamura M, Matsuda Y, Ohkoshi S, Inoue M, Wakai T, Shirai Y,
Nomoto M and Aoyagi Y: Reduced NKG2D ligand expression in
hepatocellular carcinoma correlates with early recurrence. J
Hepatol. 56:381–388. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Morisaki T, Onishi H, Koya N, Kiyota A,
Tanaka H, Umebayashi M, Ogino T, Nagamatsu I and Katano M:
Combinatorial cytotoxicity of gemcitabine and cytokine-activated
killer cells in hepatocellular carcinoma via the NKG2D-MICA/B
system. Anticancer Res. 31:2505–2510. 2011.PubMed/NCBI
|
|
29
|
Pan N, Jiang W, Sun H, Miao F, Qiu J, Jin
H, Xu J, Shi Q, Xie W and Zhang J: KIR and HLA loci are associated
with hepatocellular carcinoma development in patients with
hepatitis B virus infection: A case-control study. PLoS One.
6:e256822011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Townsley E, O'Connor G, Cosgrove C, Woda
M, Co M, Thomas SJ, Kalayanarooj S, Yoon IK, Nisalak A,
Srikiatkhachorn A, et al: Interaction of a dengue virus NS1-derived
peptide with the inhibitory receptor KIR3DL1 on natural killer
cells. Clin Exp Immunol. Oct 6–2015.(Epub ahead of print).
PubMed/NCBI
|
|
31
|
Bachanova V, McCullar V, Lenvik T, Wangen
R, Peterson KA, Ankarlo DE, Panoskaltsis-Mortari A, Wagner JE and
Miller JS: Activated notch supports development of cytokine
producing NK cells which are hyporesponsive and fail to acquire NK
cell effector functions. Biol Blood Marrow Transplant. 15:183–194.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gong J, Liu R, Zhuang R, Zhang Y, Fang L,
Xu Z, Jin L, Wang T, Song C, Yang K, et al: miR-30c-1* promotes
natural killer cell cytotoxicity against human hepatoma cells by
targeting the transcription factor HMBOX1. Cancer Sci. 103:645–652.
2012. View Article : Google Scholar : PubMed/NCBI
|
